NeuroPace, Inc.
(NASDAQ : NPCE)

( )
NPCE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.45%458.961.0%$721.87m
ABTAbbott Laboratories 0.72%118.290.8%$614.91m
MDTMedtronic Plc 0.77%125.140.6%$528.59m
DHRDanaher Corp. 0.39%253.650.7%$510.15m
ISRGIntuitive Surgical, Inc. 1.56%833.382.3%$509.12m
BDXBecton, Dickinson & Co. -0.66%242.481.0%$368.51m
BSXBoston Scientific Corp. -0.17%41.541.0%$364.50m
ALGNAlign Technology, Inc. 2.79%569.046.3%$329.80m
DXCMDexCom, Inc. 2.87%333.257.8%$288.03m
SYKStryker Corp. 2.20%253.291.3%$274.34m
EWEdwards Lifesciences Corp. 1.82%89.540.4%$251.67m
BAXBaxter International, Inc. 0.50%83.821.8%$206.38m
AAgilent Technologies, Inc. 0.98%131.301.6%$196.63m
IDXXIDEXX Laboratories, Inc. 2.32%530.073.8%$189.57m
ZBHZimmer Biomet Holdings, Inc. 0.91%167.131.7%$174.37m

Company Profile

NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's product RNS system is designed for the treatment of medically refractory partial epilepsy includes implantable and external products. The company was founded by Robert Fischell, David Fischell, Tim Fischell, Scott Fischell, Rebecca L. Kuhn, Frank M. Fischer and Martha Morrell on November 19, 1997 and is headquartered in Mountain View, CA.